Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.563%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.50
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Capital Partner - Integrum Care

2 Apr 2024 07:00

RNS Number : 9028I
Duke Capital Limited
02 April 2024
 

02 April 2024

 

Duke Capital Limited

 

("Duke Capital", "Duke" or the "Company")

 

New Capital Partner - Integrum Care

Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to announce that it has entered into a £14.5 million financing agreement (the "Financing") with a newly formed entity, to acquire Integrum Care - Clearbrook Limited trading as Integrum Care Group ("Integrum"), further diversifying Duke's revenue base. Integrum operates six elderly nursing care homes in Kent and East Sussex.

Highlights:

 

· Duke's initial £14.5 million financing will be used to acquire Integrum, as well as replace a rent deposit with the owner of Integrum's leasehold properties

· Integrum has completed six acquisitions of elderly care homes across the Kent and East Sussex regions of England within the past six years. Four of the sites were sold and subsequently leased back in 2022, whilst two freehold properties have been retained

· Duke intends to support Integrum's ongoing buy-and-build strategy, recognising Integrum's strength as a platform and its impressive management team with a strong track record in the elderly care sector

· Integrum's care homes are well maintained, with strong occupancy levels and good Care Quality Commission ratings. These care homes have a diversified funding mix between private healthcare payors, the NHS and Local Authorities

· The Financing has been agreed on typical Duke terms: 30-year secured financing, monthly cash payments starting in typical range, distributions commencing immediately and to be adjusted annually based on Integrum's consolidated revenue growth

· Duke will also become a 49% equity shareholder in Integrum, building strong alignment with our new capital partner

 

Neil Johnson, CEO of Duke Capital, said:

"Duke is excited to invest in Integrum and looks forward to contributing to its ongoing success in the future. For us, it represents the ideal platform to support within this sub-sector, primarily because it is overseen by an exceptional team led by Adrian Pancott, who brings a wealth of experience to the table.

"Integrum has demonstrated a strong track record of buying and integrating quality elderly nursing care homes run by best-in-class home managers and we look forward to supporting the group as it embarks on its next phase of growth."

Adrian Pancott, CEO of Integrum, said:

 

"Duke's unique capital offering is a great fit for Integrum at this time as we look to continue to invest in and improve the homes we already own, whilst looking to further M&A. Duke's existing Social Care sector expertise and the importance they place on quality of care makes them the perfect partner for us, and we are delighted about the opportunity to work together going forward. The whole Duke team operates with the highest levels of integrity and have inspired everyone at Integrum from the first day we met them."

 

Further information regarding Integrum

 

Integrum Care Group was formed in September 2018 and currently represents a family of six elderly care homes across the South East of England, employing over 475 people and catering for over 300 service users. The group focuses on nursing care within the elderly care industry, providing full residential care typically for residents with higher acuity needs.

 

The homes are a mix of purpose-built and converted properties with long-standing operations, with some homes having supported their local communities for more than 50 years.

 

Adrian Pancott is Integrum's CEO and brings a wealth of experience in the elderly care sector, with 20 years of operational experience in leading some of the largest care businesses across specialist and elderly care throughout the UK. Adrian was previously COO of Barchester, where he was responsible for all operational elements of the £2.5bn business with annual turnover of £600m and 17,000 employees. Before this, Adrian spent three years working for the Priory Group as the CEO of their elderly care division.

 

About the Financing

 

Duke has committed an initial £14.5 million of capital, while also agreeing in principle to potentially increase its investment in Integrum with future tranches of capital. With regard to further care home acquisitions, Integrum's stated acquisition criteria align closely with Duke's own.

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a combination of a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in April 2024.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in total combined gross revenues of the Group for the most recently completed financial year (year end December), compared to the prior financial (calendar) year. The first adjustment will occur in April 2025. The annual adjustment in the Distribution will be subject to a -/+ 6% collar.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Integrum utilises an early buyback option which will trigger an early buyout payment to Duke.

Duke Capital Portfolio

A full list of Duke's current Partners is included for reference on the Partners page of the Company's website: www.dukecapital.com/partners.

 

 

***ENDS***

 

For further information, please visit www.dukecapital.com or contact:

 

Duke Capital Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson 

+44 (0) 207 220 0500

 

Canaccord Genuity Limited

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (Financial Communications)

Elisabeth Cowell / Alice Cho / Matthew Elliott

+ +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk

 

 

About Duke Capital

 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. Its three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits. Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGGDMMDGDZZ
Date   Source Headline
22nd Mar 20197:00 amRNSDirector's Dealings
19th Mar 20197:00 amRNSDividend Declaration
14th Mar 20197:00 amRNSChange of Adviser
19th Feb 20197:00 amRNSNew Royalty Finance Agreement
5th Feb 20191:50 pmRNSHolding(s) in Company
4th Feb 20197:00 amRNSAcquisition of UK royalty finance provider
17th Dec 20187:00 amRNSFollow-on contribution to royalty partner
5th Dec 20187:00 amRNSIssue of Shares and Total Voting Rights
4th Dec 20187:00 amRNSInterim results and dividend declaration
27th Nov 201811:31 amRNSDuke Royalty to Present at Mello London
31st Oct 20187:00 amRNSLTIP Awards and other Issuances
30th Oct 20187:00 amRNSOperational and Corporate Update
28th Sep 20187:00 amRNSFurther Contribution to Royalty Partner
24th Sep 20187:00 amRNSFinal Results and Notice of AGM
20th Sep 20187:00 amRNSDividend Declaration and Notice of Results
30th Aug 20187:00 amRNSNew Royalty Agreement
6th Aug 20184:50 pmRNSNotification of major holdings
6th Aug 20184:45 pmRNSNotification of major holdings
6th Aug 20183:18 pmRNSHolding(s) in Company
6th Aug 20181:18 pmRNSNotification of Major Holdings
2nd Aug 201812:20 pmRNSResult of EGM and Issue of Equity
16th Jul 20187:00 amRNSFundraising to raise £44m and EGM announcement
13th Jul 20184:56 pmRNSFundraising to raise £44 million and notice of EGM
19th Jun 20187:00 amRNSInterim Dividend Increase
14th Jun 20187:01 amRNSRoyalty finance agreement LOI and secured loan
14th Jun 20187:00 amRNSUpdate on Exclusive Collaboration
8th May 20187:00 amRNSOperational Update on Royalty Partners
26th Apr 20187:00 amRNSFurther Contribution to Royalty Partner
24th Apr 20187:00 amRNSNew Royalty Agreement
16th Apr 20181:34 pmRNSDuke Royalty at Berenberg UK Corporate Conference
13th Mar 20187:00 amRNSInterim Dividend Increase & Dividend Declaration
8th Mar 20187:00 amRNSDirector/PDMR Shareholdings
6th Mar 20187:00 amRNSLong Term Incentive Plan Awards
5th Mar 20187:00 amRNSNew Royalty Finance Agreement
27th Feb 20187:00 amRNSDuke Royalty Appoints Redleaf Communications
2nd Jan 20184:51 pmRNSHolding(s) in Company
22nd Dec 201712:09 pmRNSHolding(s) in Company
21st Dec 201710:36 amRNSResult of EGM and Issue of Equity
19th Dec 201712:49 pmRNSInterim Dividend
5th Dec 20173:18 pmRNSResult of the Fundraising and Notice of EGM
4th Dec 20174:48 pmRNSProposed Fundraising to raise at least £20 million
13th Nov 20179:39 amRNSFurther Contribution to Royalty Partner
8th Nov 20177:05 amRNSUnaudited Interim Results
8th Nov 20177:00 amRNSStrategic Advisory Agreement
9th Oct 201711:01 amRNSDirector/PDMR Shareholding
6th Oct 20177:00 amRNSNew Royalty Finance Agreement
28th Sep 20172:47 pmRNSBoard changes and investment team addition
27th Sep 201711:46 amRNSResult of AGM
21st Sep 20173:14 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSChange of Adviser and Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.